Arcadia Biosciences

RKDA

Market cap $1.39M

RKDA Hedge Fund Activity: Q1 2026 in Review

16 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2026, worth a combined $482K — up 523% from $77.4K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RKDA positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $312K. The largest seller was Osaic Holdings, exiting entirely with an estimated $148 sold.

• 16 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2026, up from 13 in Q4 2025.
• Funds reported $482K of Arcadia Biosciences stock for Q1 2026, up 523% quarter-over-quarter.
• 6 funds opened new Arcadia Biosciences positions in Q1 2026 and 2 closed out, a net change of +4 holders.
• The largest Arcadia Biosciences buyer in Q1 2026 was Armistice Capital, an estimated $312K added.
• The largest Arcadia Biosciences seller in Q1 2026 was Osaic Holdings, an estimated $148 sold.

Based on aggregated 13F filings for Q1 2026.